Back to today’s briefing

Story perspectives

Trump Strikes Deals to Lower Drug Prices, Faces Criticism

12/23/2025

45 6

Summary

Story summary

U.S. President Donald Trump announced agreements with nine pharmaceutical companies to lower drug prices by aligning U.S. costs with Europe.
The move follows deals with five other companies.
The White House says the deals prevent foreign nations from benefiting from U.S. innovation.
Democrats criticize the plan for lack of transparency and unmet promises.
Johnson & Johnson, AbbVie, and Regeneron are expected to follow suit soon.

1 of 1

Story summary

U.S. President Donald Trump announced agreements with nine pharmaceutical companies to lower drug prices by aligning U.S. costs with Europe.
The move follows deals with five other companies.
The White House says the deals prevent foreign nations from benefiting from U.S. innovation.
Democrats criticize the plan for lack of transparency and unmet promises.
Johnson & Johnson, AbbVie, and Regeneron are expected to follow suit soon.